Home › Funds › Citigroup Inc › ENVB
Citigroup Inc position in ENVB
ENVERIC BIOSCIENCES INC · Health Care
Latest position (Q4 2025)2.28K sh
Reported value held$8.26K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 16.77K | $6.00K | New |
| Q4 2025 | 2.28K | $8.26K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENVB
- Renaissance Technologies 32.06K sh · $44.24K · Q2 2026
- Citadel Advisors 13.96K sh · $19.27K · Q2 2026
- Geode Capital Management 11.79K sh · $16.27K · Q2 2026
- Morgan Stanley 10.73K sh · $14.81K · Q2 2026
- UBS Group AG 201 sh · $277 · Q2 2026
- BlackRock Inc 51 sh · $70 · Q2 2026
- Wells Fargo & Co 1 sh · $1 · Q2 2026